TITLE

ALMIRALL AND NUEVOLUTION ENTER COLLABORATION

PUB. DATE
January 2017
SOURCE
Biotech Business;Jan2017, Vol. 30 Issue 1, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on the global strategic collaboration between medicines and medical devices provider Almirall S.A. and biotechnology company Nuevolution A/S for the development and commercialization of the RORyt inverse agonist (inhibitor) program from Nuevolution for the management of inflammatory skin diseases and disorders and psoriatic arthritis. It says that both parties will create a research collaboration for the identification of additional RORyt inhibitors.
ACCESSION #
120540016

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics